World Russia's Single-Dose Sputnik Vaccine Gets Approval Without Completing Safety Testing
Brazil regulator rejects Sputnik vaccine; Russia cries foul
RIO DE JANEIRO (AP) — Brazil's health regulator cited safety concerns while rejecting several states' requests to import almost 30 million doses of Russia's Sputnik V vaccine, prompting criticism from the Russian government. The five-person board of the Brazilian Health Regulatory Agency unanimously decided late Monday that consistent and trustworthy data required was lacking for approval of the requests from 10 states, according to a statement. Another four states and two cities have also sought authorization to import the vaccine.
Russia has approved a single-dose version of its two-dose Sputnik V vaccine without completing safety testing under scientific protocols, the Associated Press reported.
Under Russian authorities' approval, the new Sputnik Light vaccine will be marketed and given separately alongside the country's existing COVID-19 vaccines. Human testing of Sputnik Light began in January.
Vaccines aplenty but some Californians struggle to get one
SAN FRANCISCO (AP) — Hearing of excess vaccine and unfilled appointments frustrates Dr. Aaron Roland, a family physician who has been lobbying for doses to inoculate his patients, many of whom are low-income, immigrants or elderly. The San Francisco Bay Area doctor has more than 200 patients who have inquired when he will offer inoculations against the coronavirus. One patient, who is 67, said he walked into a Safeway supermarket because signs said doses were available.
"It's nice to know that this range of tools (against COVID-19) is expanding," Russian Presidentsaid on Thursday.
Studies on human trials of Sputnik Light are still underway and the dose is the same as Sputnik V's first dose.
Sputnik V will be Russia's primary vaccine, according to Russian Direct Investment Fund CEO Kirill Dmitriev, whose organization backs the vaccine financially.
He said Sputnik Light will be exported "to our international partners to help increase the rate of vaccinations in a number of countries in the face of the ongoing fight with the pandemic and new strains of coronavirus."
Sputnik Light is the fourth vaccine Russia has created and approved alongside EpiVacCorona and CoviVac.
Dmitriev said Thursday in a statement that "the single dose regimen solves the challenge of immunizing large groups in a shorter time, which is especially important during the acute phase of the spread of coronavirus, achieving herd immunity faster."
Russia, facing lags, turns to China to produce Sputnik shots
TAIPEI, Taiwan (AP) — Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot. Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as theRussia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as the U.S.
For more reporting from the Associated Press, see below.
Russian authorities argued that approving Sputnik Light could accelerate the process of achieving herd immunity against the coronavirus.
Russian Health Minister Mikhail Murashko said authorizing a fourth jab will help speed up the process of forming herd immunity against the virus. Most scientists believe at least 70% of a population needs to be immunized to achieve herd immunity against COVID-19, but the exact threshold is still unknown.
Russia faced criticism last year for authorizing Sputnik V before advanced trials had even started and for offering it to medical workers while those trials were underway. The criticism was blunted by a study published in February in the British medical journal The Lancet, which said the vaccine appeared safe and 91% effective against COVID-19 based on a trial involving about 20,000 people in Russia.
Russia 'Unlikely' to Meet Promised 630M Target for COVID Vaccine Doses, Now Partnering with China
Russia, scrambling to meet the ambitious inoculation goals it set when it first authorized its Sputnik V vaccine, will team with Chinese manufacturers to accelerate production of the vaccine in time for its target deadlines. © Pavel Golovkin, File/AP Photo In this Dec. 10, 2020, file photo, a Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow. Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot.
EpiVacCorona and CoviVac also received regulatory approval before completing large-scale testing. No data on the efficacy of the vaccines has been released.
Despite having several vaccines available and being one of the first countries to start immunizing its population, Russia is currently lagging behind a number of nations in terms of its vaccination rates.
According to Deputy Prime Minister Tatyana Golikova, 13.4 million people in Russia, or just 9% of Russia's population of 146 million, had received at least one dose of a COVID-19 vaccine as of Thursday, while 9.4 million—6% of the population—have been fully vaccinated.
Experts have questioned whether Russia will be able to meet the government's targets of vaccinating 30 million people by mid-June and nearly 69 million by August.
Newsweek, in partnership with NewsGuard, is dedicated to providing accurate and verifiable vaccine and health information. With NewsGuard's HealthGuard browser extension, users can verify if a website is a trustworthy source of health information. Visit the Newsweek VaxFacts website to learn more and to download the HealthGuard browser extension.
Alone At Sputnik V: Manuela Schwesig with Russian vaccine on voter catch
Mecklenburg-Vorpommern invests tax money in contracts via Sputnik V. Elsewhere grows back the skepticism, söder and Kretschmer rowing back. A comment. © Photo: Picture Alliance / DPA Manuela Schwesig (SPD) leads her state election campaign with empathy for Russia, from Sputnik to Nord Stream 2. D the saga around the Russian vaccine Sputnik seemed to come to an end: much noise around nothing. The chances that he is used in Germany shrink.
Mexico: Russia's Sputnik V shortages mean limited 2nd doses .
MEXICO CITY (AP) — Russian authorities have been having so many problems producing second doses of their Sputnik V coronavirus vaccine that Russia probably will be unable to supply enough to people who already got the first dose, Mexican officials said Monday. It's the latest account of production problems for Sputnik V, which the Russian government has been promising to other countries but has not been able to supply in sufficient quantities. Sputnik is unusual among coronavirus vaccines in that the two doses are different and not interchangeable.